APA (7th ed.) Citation

Anekpuritanang, T., Uataya, M., Claimon, A., Laokulrath, N., Pongsapich, W., & Pithuksurachai, P. (2021). The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation. OncoTargets and therapy, 14, 3959-3969. https://doi.org/10.2147/OTT.S308910

Chicago Style (17th ed.) Citation

Anekpuritanang, Tauangtham, Maythad Uataya, Apichaya Claimon, Natthawadee Laokulrath, Warut Pongsapich, and Paveena Pithuksurachai. "The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation." OncoTargets and Therapy 14 (2021): 3959-3969. https://doi.org/10.2147/OTT.S308910.

MLA (9th ed.) Citation

Anekpuritanang, Tauangtham, et al. "The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation." OncoTargets and Therapy, vol. 14, 2021, pp. 3959-3969, https://doi.org/10.2147/OTT.S308910.